Applied Therapeutics (APLT) Return on Sales (2023 - 2025)
Historic Return on Sales for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to 16.61%.
- Applied Therapeutics' Return on Sales rose 2160600.0% to 16.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 96.31%, marking a year-over-year decrease of 5408900.0%. This contributed to the annual value of 221.46% for FY2024, which is 2151400.0% down from last year.
- Latest data reveals that Applied Therapeutics reported Return on Sales of 16.61% as of Q3 2025, which was up 2160600.0% from 885.93% recorded in Q2 2025.
- Over the past 5 years, Applied Therapeutics' Return on Sales peaked at 30.97% during Q4 2023, and registered a low of 885.93% during Q2 2025.
- Its 3-year average for Return on Sales is 217.44%, with a median of 137.58% in 2024.
- Examining YoY changes over the last 5 years, Applied Therapeutics' Return on Sales showed a top increase of 2160600bps in 2025 and a maximum decrease of -7483500bps in 2025.
- Applied Therapeutics' Return on Sales (Quarter) stood at 30.97% in 2023, then tumbled by -798bps to 216.23% in 2024, then skyrocketed by 92bps to 16.61% in 2025.
- Its Return on Sales was 16.61% in Q3 2025, compared to 885.93% in Q2 2025 and 395.35% in Q1 2025.